GNH USA

USA — NDC

Visudyne 15 mg/1

GNH USA supplies Visudyne (Verteporfin), a photosensitizer for neovascular (wet) age-related macular degeneration. Request a quote for global supply.

Verteporfin for Injection
Visudyne
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
15 mg/1

Request sourcing

1
Pack/s

What is Verteporfin for Injection?

Verteporfin, the active ingredient in Visudyne, is a photosensitizer presented as a 15 mg/1 injection, powder, lyophilized, for solution for intravenous use. It is used to treat conditions such as neovascular (wet) age-related macular degeneration, pathologic myopia, and presumed ocular histoplasmosis.

GNH USA supplies Visudyne as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide.

What is Verteporfin for Injection used for?

Visudyne is used to treat conditions involving abnormal blood vessel growth in the eye. It is specifically indicated for the following:

- Neovascular (wet) age-related macular degeneration: Reduces leakage from abnormal blood vessels in the eye. - Pathologic myopia: Treats severe nearsightedness that causes vision loss. - Presumed ocular histoplasmosis: Manages vision loss due to fungal infection in the eye.

What are the side effects of Verteporfin for Injection?

Visudyne may cause various side effects, which can be categorized as follows:

Common Side Effects: - Back pain (temporary) - Chest pain (temporary) - Constipation - Decrease in pain or touch sensitivity - Dry, itchy, or painful eyes - Injection site reactions such as pain, redness, swelling, bleeding, discoloration, or rash - Light sensitivity - Nausea - Weakness

Serious or Rare Side Effects: - Seizures - Severe decrease in vision (often sudden) - Signs of an allergic reaction (e.g., difficulty breathing; hives; swelling of face, lips, tongue, or throat) - Appearance of light flashes or floaters - Blurred vision - Decrease in sharpness of vision - Increased blood pressure

What precautions apply to Verteporfin for Injection?

Visudyne should be used with caution and under the supervision of a healthcare professional. Important precautions include:

- Avoid use if you have porphyria or are allergic to verteporfin or any of its components. - Avoid exposure of skin or eyes to direct sunlight or bright indoor light for 2 to 5 days after treatment. - Use the largest arm vein possible, preferably the antecubital, for injection. - Monitor for signs of allergic reactions or severe vision loss. - Store at room temperature and protect from light.

What does Verteporfin for Injection interact with?

Visudyne may interact with other medications, which can be categorized as follows:

Major Interactions (Avoid): - Photosensitizing agents: May increase the risk of photosensitivity reactions. - Other medications that cause photosensitivity: May enhance the photosensitivity effects of verteporfin.

Moderate Interactions (Monitor Closely): - Medications that affect liver function: May alter the metabolism of verteporfin. - Medications that cause blood vessel constriction: May affect the efficacy of verteporfin. - Medications that cause blood vessel dilation: May affect the efficacy of verteporfin.

Frequently asked questions

What is Visudyne used for?+
Visudyne is used to treat conditions involving abnormal blood vessel growth in the eye, such as neovascular (wet) age-related macular degeneration, pathologic myopia, and presumed ocular histoplasmosis. It helps to reduce leakage from these abnormal blood vessels, slowing vision loss.
How does Verteporfin work?+
Verteporfin, the active ingredient in Visudyne, is a photosensitizer. After activation by red light (689 nm), it generates reactive oxygen species that cause selective occlusion of neovascular tissue in the eye. This process helps to block the abnormal blood vessels, reducing leakage and slowing vision loss.
What is the usual dose of Visudyne?+
The dosage of Visudyne is determined by a healthcare professional based on the patient's condition and response to treatment. It is important to follow the prescribed dosage and administration instructions provided by your doctor.
Is Visudyne safe during pregnancy or breastfeeding?+
Visudyne is classified as a pregnancy category C drug, meaning it should be used during pregnancy only if the potential benefits outweigh the risks. It is not known whether Verteporfin is excreted in human milk, so caution should be exercised when administering to nursing mothers. Always consult your healthcare provider for personalized advice.
How do I order Visudyne from GNH USA?+
To order Visudyne from GNH USA, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will then reply with pricing, availability, shipping, and the import paperwork.
How does Visudyne compare to other treatments for wet AMD?+
Visudyne is one of the treatments available for wet age-related macular degeneration (AMD). It is particularly effective for the predominantly classic form of choroidal neovascularization (CNV). Other treatments may include anti-VEGF injections, which work by blocking the growth of abnormal blood vessels. The choice of treatment depends on the specific condition and the patient's response.
How should Visudyne be stored and handled?+
Visudyne should be stored at room temperature and protected from light. It is important to follow the storage instructions provided with the medication to ensure its effectiveness and safety. Always handle the medication with care and follow the administration guidelines provided by your healthcare professional.
How is Visudyne administered?+
Visudyne is administered by intravenous infusion, usually in the arm, over a 10-minute period. After a few minutes, a laser light is shone on the eye to activate the medication. This procedure is typically performed by a healthcare professional in a clinical setting.
What are the most serious risks to watch for with Visudyne?+
The most serious risks associated with Visudyne include severe decrease in vision, seizures, and signs of an allergic reaction such as difficulty breathing, hives, or swelling of the face, lips, tongue, or throat. If any of these symptoms occur, seek immediate medical attention.
Who should not use Visudyne?+
Visudyne should not be used by individuals who have porphyria, are allergic to Verteporfin or any of its components, or have severe liver dysfunction. Always consult your healthcare provider to determine if Visudyne is suitable for you.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Verteporfin for Injection
Brand
Visudyne
Strength
15 mg/1
Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Pack size
1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (24208-560-15)
Manufacturer
Bausch & Lomb Incorporated
Origin
USA

Related products